Edoardo Scarpa
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- Hydrogels: synthesis, properties, applications
Papers in
- Biomaterials 10
- Nanoparticle-Based Drug Delivery 9
-
- Advanced Drug Delivery Systems 3
- Co-authors
- Richard O. C. Oreffo (6 shared papers)Loris Rizzello (17 shared papers)Giuseppe Battaglia (10 shared papers)Alessandro Poma (7 shared papers)Jonathan I. Dawson (1 shared paper)David Gibbs (1 shared paper)Gry Hulsart‐Billström (1 shared paper)Cameron R. M. Black (1 shared paper)
- Journals
- Molecular Pharmaceutics (2 papers)Advanced Therapeutics (2 papers)Biomaterials (2 papers)Pharmaceutics (1 paper)Journal of Negative Results in BioMedicine (1 paper)
- Partner nations
- ItalyUnited KingdomSpain
In The Last Decade
Edoardo Scarpa
35 papers receiving 541 citations
Peers
Comparison fields: 5 of 101
- Biomaterials 141
- Molecular Medicine 32
- Pharmaceutical Science 28
- Biomedical Engineering 195
- Complementary and Manual Therapy 8
Countries citing papers authored by Edoardo Scarpa
This map shows the geographic impact of Edoardo Scarpa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edoardo Scarpa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edoardo Scarpa more than expected).
Fields of papers citing papers by Edoardo Scarpa
This network shows the impact of papers produced by Edoardo Scarpa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edoardo Scarpa. The network helps show where Edoardo Scarpa may publish in the future.
Co-authors
The 25 scholars most cited alongside Edoardo Scarpa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 77 | |
| 2 | 2020 | 63 | |
| 3 | 2020 | 56 | |
| 4 | 2016 | 50 | |
| 5 | 2018 | 39 | |
| 6 | 2020 | 34 | |
| 7 | 2023 | 30 | |
| 8 | 2022 | 18 | |
| 9 | 2018 | 18 | |
| 10 | 2021 | 17 | |
| 11 | 2017 | 16 | |
| 12 | 2014 | 14 | |
| 13 | 2015 | 13 | |
| 14 | 2015 | 12 | |
| 15 | 2022 | 11 | |
| 16 | 2021 | 10 | |
| 17 | 2020 | 10 | |
| 18 | 2020 | 9 | |
| 19 | 2021 | 7 | |
| 20 | 2015 | 5 |
About Edoardo Scarpa
Edoardo Scarpa is a scholar working on Biomaterials, Pharmaceutical Science, Orthopedics and Sports Medicine, Cell Biology and Molecular Biology, having authored 38 papers that have together received 547 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (9 papers), RNA Interference and Gene Delivery (5 papers), Nanoparticles: synthesis and applications (3 papers), Advanced Drug Delivery Systems (3 papers), Tuberculosis Research and Epidemiology (2 papers), Advanced Nanomaterials in Catalysis (2 papers), Cellular Mechanics and Interactions (2 papers) and Advanced Polymer Synthesis and Characterization (2 papers). The work is most often cited by research in Biomaterials (141 citations), Molecular Medicine (32 citations), Pharmaceutical Science (28 citations), Biomedical Engineering (195 citations) and Complementary and Manual Therapy (8 citations). Edoardo Scarpa has collaborated with scholars based in Italy, United Kingdom and Spain. Frequent co-authors include Richard O. C. Oreffo, Loris Rizzello, Giuseppe Battaglia, Alessandro Poma, Jonathan I. Dawson, David Gibbs, Gry Hulsart‐Billström, Cameron R. M. Black, Pujiang Shi and Nicholas D. Evans. Their work appears in journals such as Molecular Pharmaceutics, Advanced Therapeutics, Biomaterials, Pharmaceutics and Journal of Negative Results in BioMedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.